Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury

Cheng Lung Chen, Jiunn Wang Liao, Oliver Yoa Pu Hu, Li Heng Pao

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Tubular cell apoptosis significantly contributes to cisplatin-induced acute kidney injury (AKI) pathogenesis. Although KCa3.1, a calcium-activated potassium channel, participates in apoptosis, its involvement in cisplatin-induced AKI is unknown. Here, we found that cisplatin treatment triggered an early induction of KCa3.1 expression associated with HK-2 cell apoptosis, the development of renal tubular damage, and apoptosis in mice. Treatment with the highly selective KCa3.1 blocker TRAM-34 suppressed cisplatin-induced HK-2 cell apoptosis. We further assessed whether KCa3.1 mediated cisplatin-induced AKI in genetic knockout and pharmacological blockade mouse models. KCa3.1 deficiency reduced renal function loss, renal tubular damage, and the induction of the apoptotic marker caspase-3 in the kidneys of cisplatin-treated KCa3.1−/− mice. Pharmacological blockade of KCa3.1 by TRAM-34 similarly attenuated cisplatin-induced AKI in mice. Furthermore, we dissected the mechanisms underlying cisplatin-induced apoptosis reduction via KCa3.1 blockade. We found that KCa3.1 blockade attenuated cytochrome c release and the increase in the intrinsic apoptotic mediators Bax, Bak, and caspase-9 after cisplatin treatment. KCa3.1 blocking inhibited the cisplatin-induced activation of the endoplasmic reticulum (ER) stress mediator caspase-12, which is independent of calcium-dependent protease m-calpain activation. Taken together, KCa3.1 blockade protects against cisplatin-induced AKI through the attenuation of apoptosis by interference with intrinsic apoptotic and ER stress-related mediators, providing a potential target for the prevention of cisplatin-induced AKI.

Original languageEnglish
Pages (from-to)2249-2260
Number of pages12
JournalArchives of Toxicology
Volume90
Issue number9
DOIs
Publication statusPublished - Sep 1 2016
Externally publishedYes

Fingerprint

Potassium Channels
Acute Kidney Injury
Cisplatin
Apoptosis
Kidney
Endoplasmic Reticulum Stress
Caspase 12
Chemical activation
Pharmacology
Calcium-Activated Potassium Channels
Caspase 9
Cytochromes c
Caspase 3
Peptide Hydrolases

Keywords

  • Acute kidney injury
  • Cisplatin
  • KCa3.1 potassium channel
  • Tubular cell apoptosis

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury. / Chen, Cheng Lung; Liao, Jiunn Wang; Hu, Oliver Yoa Pu; Pao, Li Heng.

In: Archives of Toxicology, Vol. 90, No. 9, 01.09.2016, p. 2249-2260.

Research output: Contribution to journalArticle

Chen, Cheng Lung ; Liao, Jiunn Wang ; Hu, Oliver Yoa Pu ; Pao, Li Heng. / Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury. In: Archives of Toxicology. 2016 ; Vol. 90, No. 9. pp. 2249-2260.
@article{16a5f969161d4e5e89de0bfed600e3cb,
title = "Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury",
abstract = "Tubular cell apoptosis significantly contributes to cisplatin-induced acute kidney injury (AKI) pathogenesis. Although KCa3.1, a calcium-activated potassium channel, participates in apoptosis, its involvement in cisplatin-induced AKI is unknown. Here, we found that cisplatin treatment triggered an early induction of KCa3.1 expression associated with HK-2 cell apoptosis, the development of renal tubular damage, and apoptosis in mice. Treatment with the highly selective KCa3.1 blocker TRAM-34 suppressed cisplatin-induced HK-2 cell apoptosis. We further assessed whether KCa3.1 mediated cisplatin-induced AKI in genetic knockout and pharmacological blockade mouse models. KCa3.1 deficiency reduced renal function loss, renal tubular damage, and the induction of the apoptotic marker caspase-3 in the kidneys of cisplatin-treated KCa3.1−/− mice. Pharmacological blockade of KCa3.1 by TRAM-34 similarly attenuated cisplatin-induced AKI in mice. Furthermore, we dissected the mechanisms underlying cisplatin-induced apoptosis reduction via KCa3.1 blockade. We found that KCa3.1 blockade attenuated cytochrome c release and the increase in the intrinsic apoptotic mediators Bax, Bak, and caspase-9 after cisplatin treatment. KCa3.1 blocking inhibited the cisplatin-induced activation of the endoplasmic reticulum (ER) stress mediator caspase-12, which is independent of calcium-dependent protease m-calpain activation. Taken together, KCa3.1 blockade protects against cisplatin-induced AKI through the attenuation of apoptosis by interference with intrinsic apoptotic and ER stress-related mediators, providing a potential target for the prevention of cisplatin-induced AKI.",
keywords = "Acute kidney injury, Cisplatin, KCa3.1 potassium channel, Tubular cell apoptosis",
author = "Chen, {Cheng Lung} and Liao, {Jiunn Wang} and Hu, {Oliver Yoa Pu} and Pao, {Li Heng}",
year = "2016",
month = "9",
day = "1",
doi = "10.1007/s00204-015-1607-5",
language = "English",
volume = "90",
pages = "2249--2260",
journal = "Archiv fur Toxikologie",
issn = "0003-9446",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury

AU - Chen, Cheng Lung

AU - Liao, Jiunn Wang

AU - Hu, Oliver Yoa Pu

AU - Pao, Li Heng

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Tubular cell apoptosis significantly contributes to cisplatin-induced acute kidney injury (AKI) pathogenesis. Although KCa3.1, a calcium-activated potassium channel, participates in apoptosis, its involvement in cisplatin-induced AKI is unknown. Here, we found that cisplatin treatment triggered an early induction of KCa3.1 expression associated with HK-2 cell apoptosis, the development of renal tubular damage, and apoptosis in mice. Treatment with the highly selective KCa3.1 blocker TRAM-34 suppressed cisplatin-induced HK-2 cell apoptosis. We further assessed whether KCa3.1 mediated cisplatin-induced AKI in genetic knockout and pharmacological blockade mouse models. KCa3.1 deficiency reduced renal function loss, renal tubular damage, and the induction of the apoptotic marker caspase-3 in the kidneys of cisplatin-treated KCa3.1−/− mice. Pharmacological blockade of KCa3.1 by TRAM-34 similarly attenuated cisplatin-induced AKI in mice. Furthermore, we dissected the mechanisms underlying cisplatin-induced apoptosis reduction via KCa3.1 blockade. We found that KCa3.1 blockade attenuated cytochrome c release and the increase in the intrinsic apoptotic mediators Bax, Bak, and caspase-9 after cisplatin treatment. KCa3.1 blocking inhibited the cisplatin-induced activation of the endoplasmic reticulum (ER) stress mediator caspase-12, which is independent of calcium-dependent protease m-calpain activation. Taken together, KCa3.1 blockade protects against cisplatin-induced AKI through the attenuation of apoptosis by interference with intrinsic apoptotic and ER stress-related mediators, providing a potential target for the prevention of cisplatin-induced AKI.

AB - Tubular cell apoptosis significantly contributes to cisplatin-induced acute kidney injury (AKI) pathogenesis. Although KCa3.1, a calcium-activated potassium channel, participates in apoptosis, its involvement in cisplatin-induced AKI is unknown. Here, we found that cisplatin treatment triggered an early induction of KCa3.1 expression associated with HK-2 cell apoptosis, the development of renal tubular damage, and apoptosis in mice. Treatment with the highly selective KCa3.1 blocker TRAM-34 suppressed cisplatin-induced HK-2 cell apoptosis. We further assessed whether KCa3.1 mediated cisplatin-induced AKI in genetic knockout and pharmacological blockade mouse models. KCa3.1 deficiency reduced renal function loss, renal tubular damage, and the induction of the apoptotic marker caspase-3 in the kidneys of cisplatin-treated KCa3.1−/− mice. Pharmacological blockade of KCa3.1 by TRAM-34 similarly attenuated cisplatin-induced AKI in mice. Furthermore, we dissected the mechanisms underlying cisplatin-induced apoptosis reduction via KCa3.1 blockade. We found that KCa3.1 blockade attenuated cytochrome c release and the increase in the intrinsic apoptotic mediators Bax, Bak, and caspase-9 after cisplatin treatment. KCa3.1 blocking inhibited the cisplatin-induced activation of the endoplasmic reticulum (ER) stress mediator caspase-12, which is independent of calcium-dependent protease m-calpain activation. Taken together, KCa3.1 blockade protects against cisplatin-induced AKI through the attenuation of apoptosis by interference with intrinsic apoptotic and ER stress-related mediators, providing a potential target for the prevention of cisplatin-induced AKI.

KW - Acute kidney injury

KW - Cisplatin

KW - KCa3.1 potassium channel

KW - Tubular cell apoptosis

UR - http://www.scopus.com/inward/record.url?scp=84944578516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944578516&partnerID=8YFLogxK

U2 - 10.1007/s00204-015-1607-5

DO - 10.1007/s00204-015-1607-5

M3 - Article

C2 - 26438401

AN - SCOPUS:84944578516

VL - 90

SP - 2249

EP - 2260

JO - Archiv fur Toxikologie

JF - Archiv fur Toxikologie

SN - 0003-9446

IS - 9

ER -